CD82 and prostate carcinoma: Data on allelic loss of KAI1 region in prostate cancers are, however, conflicting, and it has been demonstrated that LOH is infrequent in American patients (Dong et al, 1996), while frequent in Japanese (Kawana et al, 1997).